133 related articles for article (PubMed ID: 30577894)
1. A retrospective analysis of treatment and retention outcomes of pregnant and/or parenting women with opioid use disorder.
Lopian KM; Chebolu E; Kulak JA; Kahn LS; Blondell RD
J Subst Abuse Treat; 2019 Feb; 97():1-6. PubMed ID: 30577894
[TBL] [Abstract][Full Text] [Related]
2. Buprenorphine Medication for Opioid Use Disorder: A Study of Factors Associated With Postpartum Treatment Retention.
Ray-Griffith S; Tharp E; Coker JL; Catlin D; Knight B; Stowe ZN
Am J Addict; 2021 Jan; 30(1):43-48. PubMed ID: 32673447
[TBL] [Abstract][Full Text] [Related]
3. Buprenorphine medication-assisted treatment during pregnancy: An exploratory factor analysis associated with adherence.
Coker JL; Catlin D; Ray-Griffith S; Knight B; Stowe ZN
Drug Alcohol Depend; 2018 Nov; 192():146-149. PubMed ID: 30253377
[TBL] [Abstract][Full Text] [Related]
4. Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder.
Wilder C; Lewis D; Winhusen T
Drug Alcohol Depend; 2015 Apr; 149():225-31. PubMed ID: 25735465
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic.
Matson SC; Hobson G; Abdel-Rasoul M; Bonny AE
J Addict Med; 2014; 8(3):176-82. PubMed ID: 24695018
[TBL] [Abstract][Full Text] [Related]
6. Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects.
Wachman EM; Saia K; Miller M; Valle E; Shrestha H; Carter G; Werler M; Jones H
Clin Ther; 2019 Sep; 41(9):1681-1689. PubMed ID: 31358302
[TBL] [Abstract][Full Text] [Related]
7. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
[TBL] [Abstract][Full Text] [Related]
8. Development of a substance abuse program for opioid-dependent nonurban pregnant women improves outcome.
Meyer M; Benvenuto A; Howard D; Johnston A; Plante D; Metayer J; Mandell T
J Addict Med; 2012 Jun; 6(2):124-30. PubMed ID: 22517450
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with buprenorphine versus methadone use in pregnancy.
Krans EE; Bogen D; Richardson G; Park SY; Dunn SL; Day N
Subst Abus; 2016; 37(4):550-557. PubMed ID: 26914546
[TBL] [Abstract][Full Text] [Related]
10. Long-term retention in Office Based Opioid Treatment with buprenorphine.
Weinstein ZM; Kim HW; Cheng DM; Quinn E; Hui D; Labelle CT; Drainoni ML; Bachman SS; Samet JH
J Subst Abuse Treat; 2017 Mar; 74():65-70. PubMed ID: 28132702
[TBL] [Abstract][Full Text] [Related]
11. Opioid Use Disorder in Pregnancy.
Roper V; Cox KJ
J Midwifery Womens Health; 2017 May; 62(3):329-340. PubMed ID: 28561914
[TBL] [Abstract][Full Text] [Related]
12. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
[TBL] [Abstract][Full Text] [Related]
13. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
O'Connor AB; Collett A; Alto WA; O'Brien LM
J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
[TBL] [Abstract][Full Text] [Related]
14. Drug test results as a predictor of retention among patients using buprenorphine in a comprehensive outpatient treatment program.
Campbell MD; Kolodner G; Spencer RA; DuPont RL
J Addict Dis; 2016; 35(4):315-324. PubMed ID: 26757093
[TBL] [Abstract][Full Text] [Related]
15. The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder.
Krans EE; Bobby S; England M; Gedekoh RH; Chang JC; Maguire B; Genday P; English DH
Addict Behav; 2018 Nov; 86():124-129. PubMed ID: 29884421
[TBL] [Abstract][Full Text] [Related]
16. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study.
Meyer MC; Johnston AM; Crocker AM; Heil SH
J Addict Med; 2015; 9(2):81-6. PubMed ID: 25622120
[TBL] [Abstract][Full Text] [Related]
17. A Multidisciplinary Approach to the Treatment of Co-occurring Opioid Use Disorder and Posttraumatic Stress Disorder in Pregnancy: A Case Report.
Goodman DJ; Milliken CU; Theiler RN; Nordstrom BR; Akerman SC
J Dual Diagn; 2015; 11(3-4):248-57. PubMed ID: 26457976
[TBL] [Abstract][Full Text] [Related]
18. Opioid Addiction in Pregnancy: Does Depression Negatively Impact Adherence With Prenatal Care?
Hensley L; Sulo S; Kozmic S; Parilla BV
J Addict Med; 2018; 12(1):61-64. PubMed ID: 29068826
[TBL] [Abstract][Full Text] [Related]
19. Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program.
Bachhuber MA; Thompson C; Prybylowski A; Benitez J; Mazzella S; Barclay D
Subst Abus; 2018; 39(2):167-172. PubMed ID: 29474119
[TBL] [Abstract][Full Text] [Related]
20. Delayed villous maturation in term placentas exposed to opioid maintenance therapy: a retrospective cohort study.
Serra AE; Lemon LS; Mokhtari NB; Parks WT; Catov JM; Venkataramanan R; Caritis SN
Am J Obstet Gynecol; 2017 Apr; 216(4):418.e1-418.e5. PubMed ID: 28024988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
